Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment?
Hanley
N A
NA
Centre for Human Development, Stem Cells & Regeneration, University of Southampton, Southampton General Hospital, Southampton, UK. N.A.Hanley@soton.ac.uk
D015703:Antigens, CD / Q000502:physiology; D001786:Blood Glucose / Q000378:metabolism; D001808:Blood Vessels / Q000503:physiopathology*; D001854:Bone Marrow Cells / Q000502:physiology*; D003920:Diabetes Mellitus / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000503:physiopathology; D006801:Humans; D008833:Microcirculation / Q000502:physiology*; D013234:Stem Cells / Q000502:physiology*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000502:physiology
D015703:Antigens, CD; D001786:Blood Glucose; D040301:Vascular Endothelial Growth Factor Receptor-2